Histone deacetylase inhibitors as cancer therapeutics
Author(s)
Bibliographic Information
Histone deacetylase inhibitors as cancer therapeutics
(Advances in cancer research / edited by George Klein and Sidney Weinhouse, v. 116)
Academic Press is an imprint of Elsevier, 2012
- hbk.
- hbk.
Available at / 9 libraries
-
No Libraries matched.
- Remove all filters.
Description and Table of Contents
Description
Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."
Table of Contents
Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins
Mechanisms of Resistance to Histone Deacetylase Inhibitors
HDAC Inhibitors: Roles of DNA Damage and Repair
HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer
Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity
Histone Deacetylase Inhibitors and Rational Combination Therapies
HDAC Inhibitors and Chaperone Function
by "Nielsen BookData"